Role of mTOR signaling in tumor cell motility, invasion and metastasis

H Zhou, S Huang - Current Protein and Peptide Science, 2011 - ingentaconnect.com
Tumor cell migration and invasion play fundamental roles in cancer metastasis. The
mammalian target of rapamycin (mTOR), a highly conserved and ubiquitously expressed …

Oncogenic Ras in tumour progression and metastasis

K Giehl - 2005 - degruyter.com
The ras genes give rise to a family of related GTP-binding proteins that exhibit potent
transforming potential. Mutational activation of Ras proteins promotes oncogenesis by …

Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis

D Ramchandani, M Berisa, DA Tavarez, Z Li… - Nature …, 2021 - nature.com
Copper serves as a co-factor for a host of metalloenzymes that contribute to malignant
progression. The orally bioavailable copper chelating agent tetrathiomolybdate (TM) has …

Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size

A Saci, LC Cantley, CL Carpenter - Molecular cell, 2011 - cell.com
Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that exists in two
separate complexes, mTORC1 and mTORC2, that function to control cell size and growth in …

Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells

G Zhao, X Han, S Zheng, Z Li, Y Sha… - Oncology …, 2016 - spandidos-publications.com
Melanoma is the foremost malignant cutaneous cancer and it is extremely resistant to
chemotherapy and radiotherapy. Curcumin is an active component of turmeric, the yellow …

Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway

X Pang, Z Yi, J Zhang, B Lu, B Sung, W Qu… - Cancer research, 2010 - AACR
Understanding the molecular basis and target of traditional medicine is critical for drug
development. Celastrol, derived from Trypterygium wilfordii Hook F.(“Thunder of God Vine”) …

miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway

I Riquelme, O Tapia, P Leal, A Sandoval, MG Varga… - Cellular oncology, 2016 - Springer
Background Gastric cancer (GC) is a deadly malignancy worldwide. In the past, it has been
shown that cellular signaling pathway alterations play a crucial role in the development of …

Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways

L Liu, F Li, JA Cardelli, KA Martin, J Blenis, S Huang - Oncogene, 2006 - nature.com
Rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR), inhibits tumor cell
motility. However, the underlying mechanism is poorly understood. Here, we show that …

Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells

YJ Jeong, Y Choi, JM Shin, HJ Cho, JH Kang… - Food and Chemical …, 2014 - Elsevier
Bee venom is a natural compound produced by the honey bee (Apis mellifera), and has
been reported as having the biological and pharmacological activities, including anti …

The Rheb–mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord

S Codeluppi, CI Svensson, MP Hefferan… - Journal of …, 2009 - Soc Neuroscience
Astrocytes in the CNS respond to tissue damage by becoming reactive. They migrate,
undergo hypertrophy, and form a glial scar that inhibits axon regeneration. Therefore …